| NCT Number | NCT07165847 |
| Lead Sponsor | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University |
| Conditions | Immunotherapy, Gastric Cancer (GC), Radiotherapy, Neoadjuvant Therapy, Neoadjuvant Chemoimmunotherapy |
| Enrollment | 40 participants |
| Start Date | 2025-07-23 |
| Primary Completion | 2028-09-23 (estimated) |
| Study Completion | 2030-12-31 (estimated) |
| Updated on ClinicalTrials.gov | 2025-09-10 |